Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lelli

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
La Clinica Terapeutica|June 11, 1998
[High dose chemotherapy in metastatic carcinoma of the breast]G Lelli, A Tartarone, C D'Addetta, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1987
4'-Epidoxorubicin plus cisplatin as first-line therapy in the treatment of small cell bronchogenic carcinomaG Lelli, M Casadio, S Giordani, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|August 1, 1986
Phase II studies on weekly cisplatinum plus epirubicin or etoposide in the treatment of advanced non-small cell bronchogenic carcinomaG Lelli, M Casadio, C Giuliotti, et al.
La Clinica Terapeutica|December 8, 1998
[High-dose chemotherapy of metastatic breast carcinoma]A Tartarone, M Aieta, M G Morritti, et al.
Pathologica|March 10, 2001
[Primary tumors of the central nervous system: histogenetic classification, grade of malignity, clinico-pathologic features, and therapeutic criteria]M Bisceglia, V D'Angelo, S Parisi, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 1994
Combined chemo-immuno-hormonotherapy of advanced renal cell carcinomaA Panetta, A Martoni, M Guaraldi, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|October 1, 1984
The effect of high dose medroxyprogesterone acetate on water and salt metabolism in advanced cancer patientsG Lelli, B Angelelli, L Zanichelli, et al.
Journal of Chemotherapy (Florence, Italy)|August 1, 1989
Low dose intermittent 5-fluorouracil, epirubicin and cyclophosphamide (FEC) in poor risk patients with advanced transitional cell bladder cancer: a pilot studyG Lelli, A Tononi, P Bacchetti, et al.
Biopharmaceutics & Drug Disposition|December 18, 2001
Effect of age and single versus multiple dose pharmacokinetics of letrozole (Femara) in breast cancer patientsC U Pfister, A Martoni, C Zamagni, et al.
Anticancer Research|July 25, 1998
Standard interleukin-2 (IL-2) and interferon-alpha immunotherapy versus an IL-2 and 4-epirubicin immuno-chemotherapeutic association in metastatic renal cell carcinomaE Naglieri, V Gebbia, E Durini, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
La Clinica Terapeutica|June 11, 1998
[High dose chemotherapy in metastatic carcinoma of the breast]G Lelli, A Tartarone, C D'Addetta, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1987
4'-Epidoxorubicin plus cisplatin as first-line therapy in the treatment of small cell bronchogenic carcinomaG Lelli, M Casadio, S Giordani, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|August 1, 1986
Phase II studies on weekly cisplatinum plus epirubicin or etoposide in the treatment of advanced non-small cell bronchogenic carcinomaG Lelli, M Casadio, C Giuliotti, et al.
La Clinica Terapeutica|December 8, 1998
[High-dose chemotherapy of metastatic breast carcinoma]A Tartarone, M Aieta, M G Morritti, et al.
Pathologica|March 10, 2001
[Primary tumors of the central nervous system: histogenetic classification, grade of malignity, clinico-pathologic features, and therapeutic criteria]M Bisceglia, V D'Angelo, S Parisi, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 1994
Combined chemo-immuno-hormonotherapy of advanced renal cell carcinomaA Panetta, A Martoni, M Guaraldi, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|October 1, 1984
The effect of high dose medroxyprogesterone acetate on water and salt metabolism in advanced cancer patientsG Lelli, B Angelelli, L Zanichelli, et al.
Journal of Chemotherapy (Florence, Italy)|August 1, 1989
Low dose intermittent 5-fluorouracil, epirubicin and cyclophosphamide (FEC) in poor risk patients with advanced transitional cell bladder cancer: a pilot studyG Lelli, A Tononi, P Bacchetti, et al.
Biopharmaceutics & Drug Disposition|December 18, 2001
Effect of age and single versus multiple dose pharmacokinetics of letrozole (Femara) in breast cancer patientsC U Pfister, A Martoni, C Zamagni, et al.
Anticancer Research|July 25, 1998
Standard interleukin-2 (IL-2) and interferon-alpha immunotherapy versus an IL-2 and 4-epirubicin immuno-chemotherapeutic association in metastatic renal cell carcinomaE Naglieri, V Gebbia, E Durini, et al.
Pageof 4